Fosamprenavir a promising alternative in HIV infections

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1378, 2003-01, pp. : 9-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fosamprenavir: sustained virological suppression in HIV infections

By  

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Fosamprenavir: advancing HIV protease inhibitor treatment options

By Becker Stephen   Thornton Lorna  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1995-2005

Informa Healthcare

Access to resources Recommend Favorite

Fosamprenavir + ritonavir KLEANs up HIV as well as lopinavir/ritonavir

By  

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Amprenavir or Fosamprenavir plus Ritonavir in HIV Infection: Pharmacology, Efficacy and Tolerability Profile

By Arvieux Cédric  

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 633-659

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil a promising alternative in lupus

By  

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite